Serial 79079371
Live / Registered — Registered — international registration renewed (as of 01 Apr 2021)
What this means for you
Registered since 29 Mar 2011. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79079371
- Registration number
- 3936765
- Mark type
- Design / logo
- Filed
- 10 Nov 2009
- Published for opposition
- 11 Jan 2011
- Registered
- 29 Mar 2011
Goods and services
- Class 005 — Pharmaceuticals: [ Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; agents for immunity adjustment, namely, pharmaceutical preparations for the prevention and treatment of disorders of the immune system; biological preparations for medical purposes; amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; biopharmaceuticals for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies, hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; biotherapeutic preparations and substances for medical purposes; biotechnological preparations for medical purposes; pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations ]
- Class 035 — Advertising and business services: Wholesale distributorships featuring pharmaceutical products; retail store services featuring pharmaceutical products; business intermediary services in the field of pharmaceutical products; wholesale distributorships featuring biopharmaceutical products; retail store services featuring biopharmaceutical products; business intermediary services in the field of biopharmaceutical products
- Class 040 — Treatment of materials: Treatment of biopharmaceutical materials, namely, processing finished products from raw biopharmaceutical materials; treatment service of biopharmaceutical materials for others, namely, processing finished products from raw biopharmaceutical materials for others; contract manufacturing service for others in the field of biopharmaceuticals; contract manufacturing service in the field of pharmaceuticals
- Class 042 — Scientific and technological services: Pharmaceutical research and development; [ bacteriological research; biological research; research and development for new products for others; material testing; chemistry services, namely, chemistry consultation; chemical research and analysis; technology outsourcing services on biopharmaceuticals manufacturing, namely, conducting biopharmaceutical research services for others; consulting services in the field of biotechnology; pharmaceutical drug development services with animal cell; scientific research related to genetically modified plant; biotechnology research; ] biopharmaceutical research and development [ ; medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others ]
- Class 044 — Medical, beauty and agricultural services: [ Rental of medical and health care equipment; medical product information, namely, providing an interactive holistic web site featuring health information and patient initiated, patient authorized, fee-for-service, holistic approach distance healing sessions based on the patient's specific set of symptoms, medical profile and medical record analysis and patient benefit information concerning organic and holistic products and services; medical clinics, namely, conducting clinical trials of new products for medical purposes; hospitals; medical assistance services; biopharmaceutical consulting service ]
Owner
- Celltrion Holdings Co.,Ltd., KR
- CELLTRION, INC., Incheon, KR
- CELLTRION, INC., KR
- CELLTRION, INC., KR
Prosecution history
- 21 Oct 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 02 Dec 2022 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 09 Jul 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 12 Jun 2021 — CHANGE OF OWNER RECEIVED FROM IB
- 01 Apr 2021 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 01 Apr 2021 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 24 Mar 2021 — TEAS SECTION 71 & 15 RECEIVED
- 22 Mar 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Mar 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Mar 2021 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 22 Mar 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Mar 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Mar 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 Feb 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 29 Mar 2020 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED